Cardiac lesions induced by 5-fluorouracil in the rabbit
Authors:
- C Bui-XuanCBC Bui-Xuan
- A TabibATA Tabib
- 1 June 2006
- journal article
- research article
- Published by SAGE Publications in Human & Experimental Toxicology
- Vol. 25 (6) , 305-309
Abstract
Cardiotoxicity is a rare, but well-recognized complication of treatments with the anti-cancer drug 5-fluorouracil (5FU). The underlying mechanism, however, is not fully elucidated. A spasm of the coronary arteries is often considered to be the leading cause of myocardial ischemia and decreased contractility associated with 5FU. As spasm cannot account for all reported adverse cardiac effects, the present study was undertaken to search for alternative mechanisms. Groups of six rabbits were given either a single intravenous dose of 50 mg/kg 5FU or four intravenous doses of 15 mg/kg 5FU at 7-day intervals. A third group served as control. The heart was removed shortly after death or scheduled sacrifice of the animals, to perform macroscopic and microscopic examinations of the heart and to evidence apoptosis by the TUNEL method. Following a single dose of 50 mg/kg 5FU, all animals rapidly developed a massive hemorrhagic myocardial infarct with spasms of the proximal coronary arteries. Repeated infusions of 15 mg/kg 5FU induced left ventricular hypertrophy, foci of myocardial necrosis, thickening of intra-myocardial arterioles, and disseminated apoptosis in myocardial cells of the epicardium, as well as endothelial cells of the distal coronary arteries. These results indicate that a spasm of the coronary arteries is not the only mechanism of 5FU cardiotoxicity, and that apoptosis of myocardial and endothelial cells can result in inflammatory lesions mimicking toxic myocarditis.Keywords
This publication has 18 references indexed in Scilit:
- 5-Fluorouracil–Induced Coronary VasospasmCancer Control, 2004
- 5-Fluorouracil: mechanisms of action and clinical strategiesNature Reviews Cancer, 2003
- REDUCED ANTIOXIDANT DEFENSE CAPACITY IN MYOCARDIAL TISSUE FROM GUINEA PIGS TREATED WITH 5-FLUOROURACILJournal of Toxicology and Environmental Health, Part A, 2000
- Cardiotoxicity of Chemotherapeutic AgentsDrug Safety, 2000
- Pseudomyxoma peritonei:Sudden Cardiac Death Complicating Post operative Intraperitoneal Treatment with 5-FluorouracilDigestive Surgery, 1999
- Cardiotoxicity of the Antiproliferative Compound FluorouracilDrugs, 1999
- 5-fluorouracil cardiotoxicity: A unique mechanism for ischaemic cardiopathy and cardiac failure?European Journal of Cancer, 1996
- Fluorouracil CardiotoxicityAnnals of Pharmacotherapy, 1994
- 5-Fluorouracil-induced coronary vasospasmAmerican Heart Journal, 1987
- Acute myocardial infarction in toxic cardiomyopathy without coronary obstruction.Circulation, 1975